Literature DB >> 776092

Screening for Duchenne muscular dystrophy.

V Dubowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 776092      PMCID： PMC1545963          DOI： 10.1136/adc.51.4.249

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  13 in total

1.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

2.  Creatine and creatine kinase measurement.

Authors:  M L TANZER; C GILVARG
Journal:  J Biol Chem       Date:  1959-12       Impact factor: 5.157

3.  [Study of serum creatine kinase in myopathic patients and their families].

Authors:  J C DREYFUS; G SCHAPIRA; J DEMOS
Journal:  Rev Fr Etud Clin Biol       Date:  1960-04

4.  Some properties of creatine phosphokinase.

Authors:  A H ENNOR; H ROSENBERG
Journal:  Biochem J       Date:  1954-06       Impact factor: 3.857

5.  Serum creatine phosphokinase in normal newborns.

Authors:  N Gilboa; J R Swanson
Journal:  Arch Dis Child       Date:  1976-04       Impact factor: 3.791

6.  [New CPK mass screening test in the early diagnosis of muscular diseases].

Authors:  R Beckmann; G Scheuerbrandt; A Antonik; S Antonik
Journal:  Fortschr Med       Date:  1974-11-21

7.  The activity of ATP: creatine phosphotransferase (E.C.2.7.3.2) in umbilical cord blood.

Authors:  P D Griffiths
Journal:  Clin Chim Acta       Date:  1968       Impact factor: 3.786

8.  Utilization of capillary blood for serum enzyme analysis.

Authors:  J B Bodensteiner; H Zellweger
Journal:  Helv Paediatr Acta       Date:  1970-10

9.  Creatine phospholinase in normal neonates and young infants.

Authors:  J B Bodensteiner; H Zellweger
Journal:  J Lab Clin Med       Date:  1971-05

10.  [Enzyme activity determination in progressive muscular dystrophy. IV. Serum enzymatic kinetics in the preclinical stage of the Duchenne type during the 1st 2 years of life].

Authors:  H Heyck; G Laudahn; P M Carsten
Journal:  Klin Wochenschr       Date:  1966-06-15
View more
  5 in total

1.  Duchenne muscular dystrophy: early diagnosis, and screening.

Authors: 
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

Review 2.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

3.  Carrier detection in Duchenne muscular dystrophy.

Authors:  J S Fitzsimmons; J I McLachlan; W G Reeves; D W Marriott; A M Woolfson; J Mayhew
Journal:  J Med Genet       Date:  1980-06       Impact factor: 6.318

4.  Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.

Authors:  L M Drummond
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

5.  Serum creatine kinase levels in normal females.

Authors:  R K Satapathy; R Skinner
Journal:  J Med Genet       Date:  1979-02       Impact factor: 6.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.